Literature DB >> 21889771

Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

Raquel López-Mejías1, Mercedes García-Bermúdez, Carlos González-Juanatey, Santos Castañeda, Silvia Pérez-Esteban, José A Miranda-Filloy, Carmen Gómez-Vaquero, Benjamín Fernández-Gutiérrez, Alejandro Balsa, Dora Pascual-Salcedo, Ricardo Blanco, Isidoro González-Álvaro, Javier Llorca, Javier Martín, Miguel A González-Gay.   

Abstract

INTRODUCTION: Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis. IL-6 is a key mediator of inflammation in RA. A recent study showed an association between IL6-174 G/C gene polymorphism and cardiovascular (CV) disease in UK individuals with RA. To confirm this association we assessed the influence of three IL6 gene polymorphisms in the risk of CV disease in a large series of patients with RA.
MATERIAL AND METHODS: We studied 1250 Spanish patients with RA. Besides genotyping the traditional single nucleotide polymorphism (SNP) promoter -174G/C (rs1800795), we assessed another two SNPs (rs2069827 and rs2069840) located in the IL6 gene that were selected by SNP-tagging.
RESULTS: Two-hundred and twenty (17.6%) of the 1250 patients experienced CV events. No significant differences in the genotype, allele and haplotype frequencies between RA patients with and without CV events were observed.
CONCLUSION: Our results do not confirm in a Spanish population the association of IL6 gene with CV disease in RA previously reported in the UK.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889771     DOI: 10.1016/j.atherosclerosis.2011.07.124

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

Review 2.  Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Authors:  Federico Carbone; Aldo Bonaventura; Luca Liberale; Sabrina Paolino; Francesco Torre; Franco Dallegri; Fabrizio Montecucco; Maurizio Cutolo
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

3.  CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction.

Authors:  Lidio Gonçalves Lima-Neto; Rosario Dominguez Crespo Hirata; André Ducati Luchessi; Vivian Nogueira Silbiger; Marco Antonio Stephano; Marcelo Ferraz Sampaio; Dikran Armaganijan; Mario Hiroyuki Hirata
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 4.  Atherosclerosis in juvenile idiopathic arthritis.

Authors:  Ewa Jednacz; Lidia Rutkowska-Sak
Journal:  Mediators Inflamm       Date:  2012-08-13       Impact factor: 4.711

5.  A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study.

Authors:  Cecilia P Chung; Joseph F Solus; Annette Oeser; Chun Li; Paolo Raggi; Jeffrey R Smith; C Michael Stein
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

6.  Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

Authors:  Raquel López-Mejías; Fernanda Genre; Sara Remuzgo-Martínez; Carlos González-Juanatey; Montserrat Robustillo-Villarino; Javier Llorca; Alfonso Corrales; Esther Vicente; José A Miranda-Filloy; César Magro; Beatriz Tejera-Segura; Marco A Ramírez Huaranga; Trinitario Pina; Ricardo Blanco; Juan J Alegre-Sancho; Enrique Raya; Verónica Mijares; Begoña Ubilla; María D Mínguez Sánchez; Carmen Gómez-Vaquero; Alejandro Balsa; Dora Pascual-Salcedo; Francisco J López-Longo; Patricia Carreira; Isidoro González-Álvaro; Luis Rodríguez-Rodríguez; Benjamín Fernández-Gutiérrez; Iván Ferraz-Amaro; Santos Castañeda; Javier Martín; Miguel A González-Gay
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

7.  IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.

Authors:  Michelle S M A Damen; Rabia Agca; Suzanne Holewijn; Jacqueline de Graaf; Jéssica C Dos Santos; Piet L van Riel; Jaap Fransen; Marieke J H Coenen; Mike T Nurmohamed; Mihai G Netea; Charles A Dinarello; Leo A B Joosten; Bas Heinhuis; Calin D Popa
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

8.  Relationship Between Interleukin-6 -174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients.

Authors:  Renata Sokolik; Milena Iwaszko; Jerzy Świerkot; Barbara Wysoczańska; Lucyna Korman; Piotr Wiland; Katarzyna Bogunia-Kubik
Journal:  Pharmgenomics Pers Med       Date:  2021-01-28

Review 9.  Genetic markers of cardiovascular disease in rheumatoid arthritis.

Authors:  Luis Rodríguez-Rodríguez; Raquel López-Mejías; Mercedes García-Bermúdez; Carlos González-Juanatey; Miguel A González-Gay; Javier Martín
Journal:  Mediators Inflamm       Date:  2012-08-02       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.